TrialInflammopharmacology2024
Topical Nigella sativa L. product: a new candidate for the management of diabetic peripheral neuropathy.
Seyed-Ali Khodaie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
TrialInflammopharmacology2024
Seyed-Ali Khodaie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.